MHI-I () and QuatCy-I () were compared in terms of properties important for early-stage photodynamic therapy preclinical candidates. Thus, experiments were performed to monitor dark cytotoxicities, light/dark cytotoxicity ratios, selectivity of localization in tumors over other organs, and clearance from the plasma.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919274 | PMC |
http://dx.doi.org/10.1021/acsmedchemlett.1c00640 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!